HA
Hithavachani Arcot
About Hithavachani Arcot
Data last updated:
Hithavachani Arcot is an Additional Director at Digitaldots Technologies Private Limited (since 2021) and Director at Xfusion Biologics Private Limited (since 2025). The companies operate in Information Technology and Biotechnology. The largest current company by reported revenue is Digitaldots Technologies Private Limited at ₹2.02 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Digitaldots Technologies Private Limited U72900TG2019PTC137849 | Additional Director | 11 Jun 2021 | 2019 | ₹2.02 Cr (FY 2022) | Active |
| Xfusion Biologics Private Limited U21002TS2025PTC196451 | Director | 03 Apr 2025 | 2025 | Active |
Board colleagues of Hithavachani Arcot
| Name | DIN | Company | Designation |
|---|---|---|---|
| Venkatababu Dondeti | 08647465 | Digitaldots Technologies Private Limited | Managing Director |
| Kesava Praveen Kumar | 01243581 | Xfusion Biologics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hithavachani Arcot
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hithavachani Arcot
Hithavachani Arcot currently holds 2 directorships: Digitaldots Technologies Private Limited (Additional Director, since 11 Jun 2021, revenue ₹2.02 Cr (FY 2022)); Xfusion Biologics Private Limited (Director, since 03 Apr 2025).
Hithavachani Arcot was first appointed on 11 Jun 2021 as Additional Director at Digitaldots Technologies Private Limited. The most recent appointment on record is 03 Apr 2025 at Xfusion Biologics Private Limited.
The current boards of Hithavachani Arcot's companies include Venkatababu Dondeti (Digitaldots Technologies Private Limited), Kesava Praveen Kumar (Xfusion Biologics Private Limited).